Hisse detayları

EİS Eczacıbaşı İlaç Sınai ve Finansal Yatırımlar Sanayi ve Ticaret A.Ş.

ECILCSTOCKS | TR | IST | Healthcare | Drug Manufacturers - Specialty & Generic

Profil özetiTRY 49.3Piyasa değeri TRY 33.8B

No local candle data found.

Son tespit edilen formasyonlar / setup’lar

Bu sembol ve seçili yön için son 10 Market Radar sonucu.

FormasyonTFTarama çalışmasıKalite

BullishOliver Kell Momentum Setup4H07 Nov 26, 16:1675

BullishICT Inverse FVG Setup4H07 Nov 26, 16:1682

BullishMA 8/21 Crossover4H07 Nov 26, 16:1684

BearishFibonacci Retracement Setup4H07 Nov 26, 16:16100

BullishMA 8/21 Crossover15M07 Nov 26, 09:1475

BullishSupport/Resistance Flip Setup15M07 Nov 26, 09:1478

BullishOliver Kell Momentum Setup15M07 Nov 26, 09:1482

BullishICT Order Block Setup15M07 Nov 26, 09:1486

BullishMA 21/55 Crossover15M07 Nov 26, 09:1487

BearishICT Optimal Trade Entry (OTE) Setup15M07 Nov 26, 09:1488

ECILC şirket profili

EİS Eczacıbaşı İlaç Sınai ve Finansal Yatırımlar Sanayi ve Ticaret A.Ş. (ECILC), IST borsasında işlem görür. Sektör: Healthcare. Faaliyet alanı: Drug Manufacturers - Specialty & Generic.

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment is involved in the production, marketing, and sale of medicines related to human health and veterinary medicines. The Real Estate Development segment engages in development of real estate properties; rental activities for serum facilities; and providing consulting services on land development and project management. The company was incorporated in 1951 and is based in Istanbul, Turkey. EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a subsidiary of Eczacibasi Holding A.S.

Şirketin faaliyet açıklaması veri sağlayıcısından özgün dilinde sunulmaktadır.

Yıllık

Yıllık temel veriler

2025 ve önceki yıllık dönem

Toplam gelirTRY 9.9B-14.0%

Net gelirTRY 2.1B+55.9%

Net kâr marjı21.2%+9.5 pp

Hisse başına kâr3.05+55.6%

Toplam borçTRY 3.2B-24.5%

Nakit ve nakit benzerleriTRY 4.5B+44.8%

Net borçTRY -1.4B-228.4%

Metrik20212022202320242025

Toplam gelir----TRY 3.5B--TRY 9.4B+169.9%TRY 11.5B+22.7%TRY 9.9B-14.0%

Net gelir----TRY 3B--TRY 4B+32.6%TRY 1.3B-66.1%TRY 2.1B+55.9%

Net kâr marjı----86.1%--42.3%-50.9%11.7%-72.4%21.2%+81.2%

Hisse başına kâr----4.35--5.77+32.5%1.96-66.0%3.05+55.6%

Serbest nakit akışı----TRY -1.2B--TRY 2.2B+278.2%TRY 2.1B-4.3%TRY 1.1B-47.4%

Toplam borç----TRY 3.2B--TRY 4.4B+38.0%TRY 4.2B-5.9%TRY 3.2B-24.5%

Nakit ve nakit benzerleri----TRY 916.4M--TRY 2.9B+216.3%TRY 3.1B+7.8%TRY 4.5B+44.8%

Net borç----TRY 2.3B--TRY 1.6B-32.8%TRY 1.1B-31.5%TRY -1.4B-228.4%

Çeyreklik

Çeyreklik temel veriler

Q3 2026 ve geçen yılın aynı çeyreği

Toplam gelirTRY 2.4B+7.0%

Net gelirTRY -542.1M+28.7%

Net kâr marjı-22.6%+11.3 pp

Hisse başına kâr-0.79+28.8%

Toplam borçTRY 4.7B+20.1%

Nakit ve nakit benzerleriTRY 2.5B+16.5%

Net borçTRY 2.3B+24.2%

MetrikQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Toplam gelir----TRY 2.9B--TRY 3B--TRY 2.7B--TRY 2.2B--TRY 2.4B-18.0%

Net gelir----TRY 643M--TRY -481.7M--TRY -924M--TRY -760.5M--TRY -542.1M-184.3%

Net kâr marjı----22.0%---16.3%---33.6%---34.0%---22.6%-202.8%

Hisse başına kâr0.58--0.94-------1.35---1.11-291.4%-0.79-184.0%

Serbest nakit akışı----TRY -991.7M--TRY 116.2M--TRY -612.2M--TRY 1.9M--TRY 3.6B+464.7%

Toplam borç----TRY 3.7B--TRY 3.2B--TRY 3.9B--TRY 4B--TRY 4.7B+29.1%

Nakit ve nakit benzerleri----TRY 5.1B--TRY 4.5B--TRY 3.7B--TRY 2.1B--TRY 2.5B-51.2%

Net borç----TRY -1.4B--TRY -1.4B--TRY 191.1M--TRY 1.8B--TRY 2.3B+262.4%

Sahiplik

Kurumsal sahiplik özeti

2026 Q4, quarter ended 2026-11-07

PeriodSahiplikKurumlar13F paylarıToplam yatırımPozisyonlar